CuraFi Header Image

ACO REACH

Right Patient, Right Drug

Software, care navigation, and risk/financial solutions for instant savings in ACO REACH.

Clinically Validated to Lower Part B Drug Costs

Enter # of ACO beneficiaries:


Potential savings:

$7,700,000

Unmanaged

Cost-effective care

Outpatient

HOPD

Part B Drug Cost

ACO Risk:

$13.6M

CuraFi Managed

Unlock infusion capability

Part B Drug Cost

Outpatient

Outpatient/Home

Biosimilars

Convert to Part D

ACO Risk:

$5.9M

Are you leaving money on the table?

Get a savings report unique to your group and free 30-minute consultation with CuraFi experts.

Free of charge

Secure & confidential

1-week turnaround

Reward Specialists for High Value Care

  • Identify and drive referrals to high value specialists
  • Quality Bonuses for specialists who follow Clinical Guidelines and utilize biosimilars
  • Develop risk carveouts for key disease states
Physician Map

Activate In-Office Infusions, Risk-Free

  • Turnkey services for any PCP or Specialist office to do infusions or injectables
  • Centralized Drug purchasing, patient scheduling, and logistics
  • Inventory entirely financed so Provider is not at financial risk for the drug
Physician Data

Real Time Visibility into Ongoing Part B Drug Risk

  • Software forecasts potential risks to ACO as new drugs come to market
  • Anticipate prescribing behavior of specialists and KOLs in any geography
  • Updated clinical evidence, FDA labels, etc. for Drugs in Parts B and D
Physician Map 2

Mitigate the Financial Impact of 200+ Expensive Drugs

Osteoporosis


Diabetic Retinopathy


Age-related Macular Degeneration


Diabetic macular edema


Endocrine/GLP-1


Psoriasis


Dementia & Alzheimer’s Disease


Crohn’s Disease & Ulcerative Colitis





Get a Free Customized Savings Report

Discover how much you can save with CuraFi.


[email protected]